AMPE Ampio Pharmaceuticals, Inc. gains 17% Apr 10, 2018

Ampio Pharmaceuticals, Inc., a development stage biopharmaceutical company, focuses on the development of therapies for the treatment of prevalent inflammatory conditions in the United States. The company is developing compounds that decrease inflammation by inhibiting specific pro-inflammatory compounds by affecting specific pathways at the protein expression and at the transcription level; activating specific phosphatase or depleting available phosphate needed for the inflammation process; and decreasing vascular permeability. Its product pipeline includes Ampion, an intra-articular injection for the treatment of osteoarthritis of the knee; and Optina, which has completed Phase II clinical trials for diabetic macular edema. Ampio Pharmaceuticals, Inc. is headquartered in Englewood, Colorado. http://www.priceseries.com/trade/AMPE-Ampio-Pharmaceuticals-Inc-stock-gains-17-percent-a-Trade-Record-by-priceSeries-2018032220180410.html

AMRC Ameresco, Inc. gains 22% Apr 9, 2018

Ameresco, Inc. provides comprehensive energy services for businesses and organizations in North America and Europe. It offers energy efficiency, infrastructure upgrades, energy security and resilience, asset sustainability, and renewable energy solutions. The company operates through U.S. Regions, U.S. Federal, Canada, and Small-Scale Infrastructure segments. It designs, develops, engineers, and installs projects that reduce the energy, as well as operations and maintenance costs of customers' facilities. The company's projects primarily include various measures customized for the facility and designed to enhance the efficiency of building systems, such as heating, ventilation, cooling, and lighting systems. It also offers renewable energy products and services, such as the construction of small-scale plants for customers that produce electricity, gas, heat, or cooling from renewable sources of energy; and sells electricity and processed renewable gas fuel, heat, or cooling. In addition, the company provides enterprise energy management and consulting services; and sells solar photovoltaic (PV) energy products and systems. It serves federal, state, and local governments, as well as healthcare and educational institutions, housing authorities, and commercial and industrial customers. As of December 31, 2016, the company owned and operated 55 small-scale renewable energy plants and solar PV installations. Ameresco, Inc. was founded in 2000 and is headquartered in Framingham, Massachusetts. http://www.priceseries.com/trade/AMRC-Ameresco-Inc-stock-gains-22-percent-a-Trade-Record-by-priceSeries-2018030620180409.html

RUN Sunrun Inc. gains 21% Apr 6, 2018

Sunrun Inc. engages in the design, development, installation, sale, ownership, and maintenance of residential solar energy systems in the United States. It also sells solar leads. The company markets and sells its products through direct channels, partner channels, mass media, digital media, canvassing, referral, retail, and field marketing. Sunrun Inc. was founded in 2007 and is headquartered in San Francisco, California. http://www.priceseries.com/trade/RUN-Sunrun-Inc-stock-gains-21-percent-a-Trade-Record-by-priceSeries-2018030920180406.html

ARQL ArQule, Inc. gains 67% Apr 6, 2018

ArQule, Inc., a biopharmaceutical company, researches and develops therapeutics for the treatment of cancer and rare diseases in the United States. Its lead product candidate is tivantinib (ARQ 197), a small molecule inhibitor of the c-Met receptor tyrosine kinase and its biological pathway, which is in Phase III clinical trial for the treatment of liver cancer. The company's clinical-stage products include ARQ 087, a multi-kinase inhibitor of the fibroblast growth factor receptor family Phase II clinical trial for patients with intrahepatic cholangiocarcinoma and in Phase Ib for multiple oncology indications; ARQ 092, an inhibitor of the AKT serine/threonine kinase in Phase I clinical trials for multiple oncology indications; ARQ 751, a next-generation inhibitor of AKT in Phase I clinical trial for solid tumors; and ARQ 761, an intravenously administered analogue of Beta-lapachone, which is Phase 1b clinical trial used as a promoter of NQo1-mediated programmed cancer cell death. Its pre-clinical development program also includes ARQ 531, an inhibitor of Bruton's tyrosine kinase. The company has co-development and co-commercialization agreement with Daiichi Sankyo Co., Ltd.; license agreement with Kyowa Hakko Kirin Co., Ltd.; and collaborative research and development agreement with Beryllium Development Corp. Arqule, Inc. was founded in 1993 and is headquartered in Burlington, Massachusetts. http://www.priceseries.com/trade/ARQL-ArQule-Inc-stock-gains-67-percent-a-Trade-Record-by-priceSeries-2018030620180406.html

CRVS Corvus Pharmaceuticals Inc gains 21% Apr 5, 2018

Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology therapies that are designed to harness the immune system to attack cancer cells. Its lead product candidate is CPI-444, an oral, small molecule antagonist of the A2A receptor that plan to initiate a Phase 1/1b clinical trial for adenosine, an immune checkpoint. The company also develops a product candidate, an anti-CD73 monoclonal antibody that inhibits the production of adenosine. Corvus Pharmaceuticals, Inc. was founded in 2014 and is based in Burlingame, California. http://www.priceseries.com/trade/CRVS-Corvus-Pharmaceuticals-Inc-stock-gains-21-percent-a-Trade-Record-by-priceSeries-2018030620180405.html

SGH SMART Global Holdings, Inc. - O gains 34% Apr 4, 2018

N/A http://www.priceseries.com/trade/SGH-SMART-Global-Holdings-Inc---O-stock-gains-34-percent-a-Trade-Record-by-priceSeries-2018030220180404.html

TUES Tuesday Morning Corp. gains 18% Apr 3, 2018

Tuesday Morning Corporation operates as a retailer of upscale decorative home accessories, housewares, seasonal goods, and gifts in the United States. The company offers various products, such as home decor, furniture, bed and bath, kitchen, toys, crafts, pets, and seasonal goods, as well as home furnishings items. It also provides a range of branded merchandise, including Peacock Alley, Sferra, Lenox, Waterford, and Hartmann. The company operated 750 discount retail stores in 41 states. Tuesday Morning Corporation was founded in 1974 and is headquartered in Dallas, Texas. http://www.priceseries.com/trade/TUES-Tuesday-Morning-Corp-stock-gains-18-percent-a-Trade-Record-by-priceSeries-2018030220180403.html

XL XL Group plc gains 27% Apr 2, 2018

XL Group Ltd, through its subsidiaries, operates as an insurance and reinsurance company worldwide. The company operates in two segments: Insurance and Reinsurance. The Insurance segment offers casualty programs comprising primary and excess casualty, environmental liability, and excess and surplus lines; energy, property, and construction insurance; professional lines, such as directors', officers' liability, errors and omissions, employment practices, crime, fiduciary, technology, and cyber liability coverages; and specialty lines, including the aviation and satellite, marine, fine art and specie, equine, livestock and aquaculture, crisis management, political risk, trade credit and life, and accident and health insurance products. The Reinsurance segment provides casualty reinsurance products, including general and professional liability, and automobile liability and workers' compensation; property reinsurance products comprising property catastrophe, property risk excess of loss, and property proportional; specialty reinsurance products, such as energy, marine, aviation, and space; and other reinsurance products, including fidelity, surety, trade credit, accident and health, mortgage, and political risk. It also writes whole account capital gearing quota share contracts on select syndicates at Lloyd's. The company markets its products and services to the industrial, commercial, professional, and insurance companies, as well as other enterprises through international, national, and regional producers, acting as the brokers and representatives of policyholders. XL Group Ltd was founded in 1986 and is based in Hamilton, Bermuda. http://www.priceseries.com/trade/XL-XL-Group-plc-stock-gains-27-percent-a-Trade-Record-by-priceSeries-2018030220180402.html

SRDX SurModics, Inc. gains 23% Apr 2, 2018

Surmodics, Inc., together with its subsidiaries, provides surface modification and in vitro diagnostic technologies to the healthcare industry worldwide. It operates through two segments, Medical Device and In Vitro Diagnostics. The Medical Device segment offers surface modification coating technologies to enhance access, deliverability, and predictable deployment of medical devices, as well as drug delivery coating technologies to provide site-specific drug delivery from the surface of a medical device for the coronary, peripheral, neuro-vascular, urology, and other markets. This segment also engages in the contract research, development, and manufacture of percutaneous transluminal angioplasty balloon catheters for use in various interventional cardiology, peripheral, and other applications. The Vitro Diagnostics segment provides component products and technologies that include protein stabilization reagents, substrates, antigens, and surface coatings for diagnostic immunoassay and molecular tests, as well as to the diagnostic, biomedical research, and life science markets. SurModics, Inc. was founded in 1979 and is headquartered in Eden Prairie, Minnesota. http://www.priceseries.com/trade/SRDX-SurModics-Inc-stock-gains-23-percent-a-Trade-Record-by-priceSeries-2018022720180402.html

RDNT RadNet, Inc. gains 30% Apr 2, 2018

RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems for the imaging industry, including picture archiving communications systems; and provides teleradiology services for remote interpretation of images on behalf of radiology groups, hospitals, and imaging center customers. It owns and/or operates 305 outpatient imaging centers located in California, Maryland, Delaware, New Jersey, New York, and Rhode Island. The company was founded in 1981 and is headquartered in Los Angeles, California. http://www.priceseries.com/trade/RDNT-RadNet-Inc-stock-gains-30-percent-a-Trade-Record-by-priceSeries-2018030720180402.html